天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook Chinese Germany Japanese Korean

上海安譜實(shí)驗(yàn)科技股份有限公司 Company Information

Company Name:    ShangHai Anpel Co, Ltd.
Tel:    -18501792038
Email:    shanpel@anpel.com.cn
Nationality:    China
WebSite:    https://www.labsci.com.cn/index
Product List:    9611
65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97

Product List
Cyclohexaneaceticacid 5292-21-7
Sebacic acid, diethyl ester 110-40-7
Photrexa 6184-17-4
trans-2-Hexen-1-ol;≥ 95.0% 928-95-0
Dihydro Capsaicin-[D3 1330261-21-6
Flunisolide Hemihydrate 77326-96-6
Di-tert-butyl Peroxide 110-05-4
Fluxametamide 928783-29-3
Monobutyrin 557-25-5
Fenoprofen 29679-58-1
Sebacic acid,bis(2-ethylhexyl)ester 122-62-3
Sodiumdiethyldithiocarbamate;97% 148-18-5
H-Gly-Gly-Gly-OH 556-33-2
Isopropyl p-Tosylate 2307-69-9
Ethyl Lignocerate, ≥ 98.0% 24634-95-5
Cholesta-3,5-diene 747-90-0
SABINENE 3387-41-5
Tetrabutylthiuram Disulfide 1634-02-2
Gibberellin a7 510-75-8
4-Amino-benzenesulfonic acid monosodium salt 515-74-2
Flutrimazole 119006-77-8
Isopropyl Methanesulfonate 926-06-7
Octyl-3,5-di-tert-butyl-4-hydroxyhydrocinnamate 125643-61-0
Sulfadiazine sodium 547-32-0
Sulfadimethoxine-[D4 1020719-80-5
Drometrizole trisiloxane 155633-54-8
Dienestrole-[D2 1346606-45-8
Diethyl 3,5-Di-tert-butyl-4-hydroxybenzylphosphonate, ≥ 98.0% 976-56-7
N-Propyl methacrylate(with 200ppm 4-methoxyphenol) 2210-28-8
Thiofanox-sulfoxide 39184-27-5
Clenpenterol 38339-21-8
Magnesium ascorbyl phosphate 114040-31-2
Calcium Ascorbate Dihydrate 5743-28-2
Cyclophosphamide 50-18-0
Pyrantel tartrate 33401-94-4
1H,1H,2H,2H-Nonafluorohexyl Methacrylate(stabilized with 120ppm MEHQ) 1799-84-4
Sodium chondroitin 6-sulfate 12678-07-8
2‘-Aminoacetophenone 551-93-9
o-Toluicacid 118-90-1
Pigment Violet 19 1047-16-1
Capsaicin-[D3](Mixture of isomers) 1185237-43-7
Rofecoxib 162011-90-7
Hexakis(2,2,3,3-tetrafluoropropoxy)phosphazene 58943-98-9
Dibenzo(a,l)pyrene 191-30-0
Disperse Yellow 49 6858-49-7
Petunidin-3-O-glucoside chloride 6988-81-4
Pilocarpine 92-13-7
Pyrimidine 289-95-2
Meclizine dihydrochloride 1104-22-9
Naftifine 65472-88-0
Imiquimod 99011-02-6
Heptafluorobutyramide 662-50-0
Tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) isocyanurate 40601-76-1
Bisoxatina 17692-24-9
2,4,6-Tris(2,4,6-tribromophenoxy)-1,3,5-triazine 25713-60-4
Thiophene 110-02-1
Dimethyl Perfluoro-1,10-decanedicarboxylate 84750-88-9
Ethyl Heptadecanoate(C17:0) 14010-23-2
Bis(4-Tert-octylphenyl)amine 15721-78-5
Ethyl Trichloroacetate, ≥ 97.0% 515-84-4
Perfluorododecyl Iodide 307-60-8
Nifursol 16915-70-1
Trifluoromethanesulfonic Acid, ≥ 98.0% 1493-13-6
Gendenafil 147676-66-2
1-Iodo-1H,1H,2H,2H-perfluorododecane 2043-54-1
Tributyl citrate 77-94-1
Perfluoroheptanesulfonic acid 375-92-8
Hydrochlorothiazide-[13C,D2 1190006-03-1
Perfluorooctanoic acid-1,2-[13C2 864071-08-9
Salsalate 552-94-3
2-Ethoxy-2-methylbutane 919-94-8
sudoxicam 34042-85-8
Perfluorooctane sulfonate diethanolamine salt (PFOS-NH(OH)2) 70225-14-8
9-Phenylanthracene 602-55-1
Calcium D,L-5-Methyltetrahydrofolate 26560-38-3
Ampicillin sodium 69-52-3
Benzalkonium Chloride 63449-41-2
Avilamycin 11051-71-1
Ethynylbenzene 536-74-3
Acemetacin 53164-05-9
Azithromycin-[D3 163921-65-1
N-(1,4-dimethylpentyl)-N'-phenylbenzene-1,4-diamine 3081-01-4
D-(+)-Cycloserine, ≥ 98.0% 68-41-7
δ-Undecanolactone, ≥ 98.0% 710-04-3
Biurea, ≥ 97.0% 110-21-4
Alitame hydrate 99016-42-9
Alpha-caryophyllene 6753-98-6
β-Ionone 14901-07-6
N,N'-Diphenyl-1,4-phenylenediamine 74-31-7
2,2',3',4,6-Pentachlorobiphenyl 60233-25-2
N,N'-Di-2-naphthyl-1,4-phenylenediamine 93-46-9
2,2‘,4,4‘,5,6‘-Hexachlorobiphenyl 60145-22-4
N,N'-Diethylthiourea 105-55-5
N-(2,4-Dimethylphenyl)formamide 60397-77-5
N-Desethyl Vardenafil 448184-46-1
Lauroylsarcosine(sodium) 137-16-6
2,2',3,3',4,4',6-Heptachlorobiphenyl 52663-71-5
N-n-Butylbenzenesulfonamide 3622-84-2
DL-Anabasine 13078-04-1
DL-VALINE 516-06-3
65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97

Copyright 2007©  ChemicalBook. All rights reserved.